Viewing Study NCT05275205


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2025-12-26 @ 2:06 AM
Study NCT ID: NCT05275205
Status: COMPLETED
Last Update Posted: 2024-08-07
First Post: 2022-02-17
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)
Sponsor: Unity Biotechnology, Inc.
Organization: